Prostate Cancer - Results from #27920

Dynamic prediction of metastases after radical prostatectomy for prostate cancer - Abstract June 15, 2011

Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: Results from a prospective phase II randomized trial - Abstract June 15, 2011

Active surveillance vs. treatment for low-risk prostate cancer: A cost comparison - Abstract June 15, 2011

Impact of common medications on serum total prostate-specific antigen levels and risk group assignment in patients with prostate cancer - Abstract June 15, 2011

Editor's Commentary - Prospective evaluation of (11)C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases June 15, 2011

Screening for prostate cancer---the controversy continues, but can it be resolved? - Abstract June 14, 2011

Pathology in prostate research: Optimizing tissue quality - Abstract June 14, 2011

New therapeutic strategies for castration-resistant prostate cancer - Abstract June 14, 2011

Psychiatric treatment in men with prostate cancer - Results from a Nation-wide, population-based cohort study from PCBaSe Sweden - Abstract June 14, 2011

Controversies in the management of localized prostate cancer: Radical prostatectomy still the standard of care - Abstract June 14, 2011

Association of obesity and smoking with PSA and PSA velocity in men with prostate cancer - Abstract June 14, 2011

Berberine suppresses androgen receptor signaling in prostate cancer - Abstract June 14, 2011

Identification of the prostate cancer index lesion by real-time elastography: Considerations for focal therapy of prostate cancer - Abstract June 14, 2011

Editor's Commentary - Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: A retrospective study June 14, 2011

SUFU 2011 - Management of GU strictures after treatment of prostatic disease - Session Highlights June 14, 2011

Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model - Abstract June 13, 2011

High intensity focused ultrasound in clinical tumor ablation - Abstract June 13, 2011

Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy - Abstract June 13, 2011

Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment - Abstract June 13, 2011

Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: Findings at radical prostatectomy - Abstract June 13, 2011

Page 1397 of 1447